Coronavirus Disease-2019 in Cancer Patients. A Report of the First 25 Cancer Patients in a Western Country (Italy)
Authors:
Open Access
- 14 May 2020
- journal article
- research article
- Published by Taylor & Francis in Future Oncology
- Vol. 16 (20) , 1425-1432
Abstract
Background: We describe cancer patients with coronavirus disease-2019 (COVID-19) infection treated at the Piacenza’s general hospital (north Italy). Materials & methods: 25 cancer patients infected...Keywords
This publication has 13 references indexed in Scilit:
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive studyThe Lancet Infectious Diseases, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020
- First imported case of 2019 novel coronavirus in Canada, presenting as mild pneumoniaThe Lancet, 2020
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor bindingThe Lancet, 2020
- Myeloid suppressor cells in cancer and autoimmunityJournal of Autoimmunity, 2017
- Features of Postoperative Immune Suppression Are Reversible With Interferon Gamma and Independent of Interleukin-6 PathwaysAnnals of Surgery, 2016
- Selective Depletion of Regulatory T Cell Subsets by Docetaxel Treatment in Patients with Nonsmall Cell Lung CancerJournal of Immunology Research, 2014
- Nosocomial infections in patients with cancerThe Lancet Oncology, 2009
- Comparison of procalcitonin and C-reactive protein as markers of sepsisCritical Care Medicine, 2003